A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies

NCT03440437 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

80

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

Advanced Cancer
Metastatic Cancer
Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: FS118
DRUG: Paclitaxel

Sponsor

invoX Pharma Limited